10129-051 : Gingi-pak Max Z-twist No 00 .197 mg/10mm Dental; Periodontal; Subgingival Solution


NDC10129-051
Labeler: Gingi-pak a Division of The Belport
Product Type: Human OTC Drug
Drug Name:  Gingi-pak Max Z-twist No 00
Dosage Form: Dental; Periodontal; Subgingival Solution
Rev. Date: 


NDC Package Codes:

  • 10129-051-01: 2740 MM IN 1 BOTTLE, PLASTIC (10129‑051‑01)

Active Ingredients:

  • Epinephrine Hydrochloride

Dosage Strength:

  • .197 mg/10mm

Pharmaceutical Classes:

  • Adrenergic alpha-Agonists [MoA]
  • Adrenergic beta-Agonists [MoA]
  • Catecholamine [EPC]
  • Catecholamines [CS]
  • alpha-Adrenergic Agonist [EPC]
  • beta-Adrenergic Agonist [EPC]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 10129-051 QR Code

< Prev: 10129-044Next: 10129-052 >

Related Discussions:

racemic epinephrine vs. l epinephrine 1:1000
Does anyone have any supporting documentation for the use of Racemic epinephrine over L epinephrine in croup patients? O... 3 replies
Dental-Articaine and Epinephrine
Is Articaine and Epinephrine used in local anaesthesia, vegetarian? I am a Jain and don't use anything made from ani... 1 reply
EPINEPHRINE
MSDS...
severe allergy to epinephrine
## I have experienced fast heart beat, uncontrollable crying, muscle spasm in calves and narrowing of esophagus so I cou... 1 reply
marcaine 0.5% with epinephrine
bupivacaine hydrochloride and epinephrine injection,marketed by Eastman Kodak...
wrong administration of epinephrine to newborn
Given .3ml of epinephrine to newborn baby instead of Vit. K ## WHOEVER DID THAT NEEDS SOME SERIOUS REMEDIATION. VIT K IS... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.